Decision letter for "Morpholine as a Privileged Scaffold for Neurodegenerative Disease Therapeutics"

Publons reviews and discussion 2026

View at publisher

DOI: 10.1039/d6ra00100a/v2/decision1

Cited by: 0

Fields of Study & Subjects

Alzheimer's disease research and treatments Cholinesterase and Neurodegenerative Diseases Heterocyclic Compound Synthesis and Bioactivity